AI and Drug Development: IP and data protection challenges

Artificial intelligence (AI) is not new to the life sciences industry but its use in drug development is rapidly growing, as life sciences companies increasingly recognize the benefits of...

Tech - Exposed in a downturn

Tech has been transformed in the last decade. Does value invested in the cloud, big data and algorithms create new risks and opportunities if there is an economic downturn. If so, what...

A turning point for Tech

Are politics and regulation fundamentally changing the climate for tech? Join us to explore what's happening, what's coming and what it means for businesses, investors and...

Tech: Who wins, who loses?

20 years after the bursting of the dotcom bubble, the business of technology is more turbulent than ever.

Artificial Intelligence and the Law

Loly Sosa presented at the “Artificial Intelligence and the Law” session of Harvard Law School’s HLS200 Bicentennial event. The discussion focused on the challenges that...

Artificial Intelligence: The Evolving Legal Landscape and Ethical Implications

Machines making decisions so that business can operate more efficiently and productively is both exciting and terrifying. Learn how the internet of things, COPPA/EdTech, and artificial...

Going Global 2017

We are hosting a cross-practice, multi-track seminar on November 16 (Tokyo) and November 13 (Osaka). Join us to find out about a new approach to brand management, the latest developments in ...

Loading data